University of Cambridge > Talks.cam > Computational and Systems Biology > Computational approaches to Immuno-Oncology drug development

Computational approaches to Immuno-Oncology drug development

Download to your calendar using vCal

If you have a question about this talk, please contact .

Abstract: Immune modifying approaches for the treatment of cancer have been wildly successful, yet approved therapies are only the tip of the iceberg. Drugs in earlier stages of development represent a broad class of agents with numerous challenges for a successful drug discovery programme. For example, how do we demonstrate intra-tumoural immune modulation from a peripheral blood sample? How do identify the patients most likely to respond to immune-therapy? Here I will discuss the bioinformatic approaches we are taking to address these questions within AstraZeneca.

This talk is part of the Computational and Systems Biology series.

This talk is included in these lists:

Note that ex-directory lists are not shown.

 

Š 2006-2025 Talks.cam, University of Cambridge. Contact Us | Help and Documentation | Privacy and Publicity